Psychologists in Vacaville, CA Accepting Medicare
87 Psychologists found. Showing 81 - 87
 Dr. Lalitha K Pieri, PSY.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 3700 Vaca Valley Pkwy, Vacaville, CA 95688 Phone: 707-453-5354 |
 Dr. Mark Nadeau Bohner, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 595 Buck Ave Ste G, Vacaville, CA 95688 Phone: 707-246-3585 |
Mr. Ramon A. Martinez, PSY.D. Psychologist - Clinical Medicare: May Accept Medicare Assignments Practice Location: 1600 California Drive, Dsh-v, App Unit Q-2, Vacaville, CA 95696 Phone: 707-448-6841 |
Dr. Roy W. Johnson, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1600 California Dr., Vacaville, CA 95656 Phone: 707-448-6841 |
Nicole Tucci, PSY.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 1600 California Dr, Vacaville, CA 95687 Phone: 707-448-6841 Fax: 707-453-7015 |
Dr. Leslie Caldwell, PSY.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 1 Quality Drive, Vacaville, CA 95688 Phone: 707-624-4000 |
Dr. Katheryn Conde, PSYD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 673 Merchant St Ste A, Vacaville, CA 95688 Phone: 707-415-7473 |
News Archive
Kidney Cancer Canada applauds Ontario for granting coverage for RCC therapy TORISEL
Ontario has taken a major step forward in access to treatment for patients in the province with advanced kidney cancer by granting coverage for TORISELTM (temsirolimus), for advanced renal cell carcinoma (RCC) with poor prognostic features.
Higher education levels increases need for symptomatic control of Parkinson's disease
Individuals who have higher levels of education and who are more impaired by Parkinson's disease appear to require treatment for their symptoms earlier than do other patients, according to a report posted online today that will appear in the September print issue of Archives of Neurology, one of the JAMA/Archives journals.
Sarepta Therapeutics plans to submit eteplirsen NDA for treatment of Duchenne muscular dystrophy
Sarepta Therapeutics, Inc., a developer of innovative RNA-based therapeutics, today announced it plans to submit a New Drug Application (NDA) to the U.S. Food and Drug Administration by the end of 2014 for the approval of eteplirsen for the treatment of Duchenne muscular dystrophy (DMD).
And about Paul Ryan...
Some conservatives want to hear more from the GOP vice presidential pick regarding his proposals for Medicare and Medicaid, and less of the campaign's more cautious talking points.
Brain atrophy in elderly leads to unintended racism, depression and problem gambling
In a study appearing in the October issue of Current Directions in Psychological Science, University of Queensland psychologist, Bill von Hippel, reports that decreased inhibitory ability in late adulthood can lead to unintended prejudice, social inappropriateness, depression, and gambling problems.
› Verified 4 days ago
Counselors
Pharmacists
Dentists
Psychologists
Clinical Social Workers
Occupational Therapists